These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38613909)

  • 1. Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts.
    Gwenzi T; Schrotz-King P; Anker SC; Schöttker B; Hoffmeister M; Brenner H
    ESMO Open; 2024 Apr; 9(4):102982. PubMed ID: 38613909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
    Hua X; Kratz M; Malen RC; Dai JY; Lindström S; Zheng Y; Newcomb PA
    Br J Cancer; 2021 Sep; 125(6):806-815. PubMed ID: 34230610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response.
    Vaughan-Shaw PG; Zgaga L; Ooi LY; Theodoratou E; Timofeeva M; Svinti V; Walker M; O'Sullivan F; Ewing A; Johnston S; Din FVN; Campbell H; Farrington SM; Dunlop MG
    Gut; 2020 Jan; 69(1):103-111. PubMed ID: 31023832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients.
    Boakye D; Jansen L; Schöttker B; Jansen EHJM; Schneider M; Halama N; Gào X; Chang-Claude J; Hoffmeister M; Brenner H
    Int J Cancer; 2020 Nov; 147(9):2373-2386. PubMed ID: 32319674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of postoperative inflammation on recurrence in patients with colorectal cancer.
    Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Konishi H; Komatsu S; Shiozaki A; Otsuji E
    Int J Clin Oncol; 2020 Apr; 25(4):602-613. PubMed ID: 31758273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Post-operative Serum C-reactive Protein Level for -Survival after Surgery for Colorectal Liver Metastases.
    van der Stok EP; Grünhagen DJ; Rothbarth J; Verhoef C
    Acta Chir Belg; 2015; 115(5):348-55. PubMed ID: 26560001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
    Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis.
    Gwenzi T; Zhu A; Schrotz-King P; Schöttker B; Hoffmeister M; Edelmann D; Brenner H
    Clin Epidemiol; 2023; 15():795-809. PubMed ID: 37396024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
    Woo HD; Kim K; Kim J
    Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
    Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
    Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
    Lumachi F; Basso SM; Santeufemia DA; Ermani M; Lo Re G; Chiara GB
    Anticancer Res; 2014 Dec; 34(12):7263-6. PubMed ID: 25503158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients.
    Yamamoto M; Saito H; Uejima C; Tanio A; Takaya S; Sakamoto T; Honjo S; Maeta Y; Ashida K; Fujiwara Y
    Surg Today; 2018 Nov; 48(11):986-993. PubMed ID: 29946884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TATI, TAT-2, and CRP as Prognostic Factors in Colorectal Cancer.
    Björkman K; Kaprio T; Beilmann-Lehtonen I; Stenman UH; Böckelman C; Haglund C
    Oncology; 2022; 100(1):22-30. PubMed ID: 34794144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
    Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
    Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
    Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R
    PLoS One; 2018; 13(4):e0195354. PubMed ID: 29630649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study.
    Liu B; Zhao Y; Guo L
    Medicine (Baltimore); 2018 Oct; 97(40):e11780. PubMed ID: 30290589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
    Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J
    Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.